These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32152145)

  • 1. Retinal cavitations in macular telangiectasia type 2 (MacTel): longitudinal structure-function correlations.
    Cai CX; Choong J; Farsiu S; Chiu SJ; Chew EY; Jaffe GJ
    Br J Ophthalmol; 2021 Jan; 105(1):109-112. PubMed ID: 32152145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Relevance of Hyper-Reflectivity in Macular Telangiectasia Type 2.
    Tzaridis S; Friedlander M;
    Invest Ophthalmol Vis Sci; 2021 Mar; 62(3):6. PubMed ID: 33661283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifocal electroretinography in patients with macular telangiectasia type 2.
    Goel N; Kumari A; Kumar S; Mehta A
    Doc Ophthalmol; 2020 Aug; 141(1):15-21. PubMed ID: 31912262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macular Telangiectasia Type 2: Visual Acuity, Disease End Stage, and the MacTel Area: MacTel Project Report Number 8.
    Heeren TFC; Chew EY; Clemons T; Fruttiger M; Balaskas K; Schwartz R; Egan CA; Charbel Issa P;
    Ophthalmology; 2020 Nov; 127(11):1539-1548. PubMed ID: 32586743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression characteristics of ellipsoid zone loss in macular telangiectasia type 2.
    Pauleikhoff D; Bonelli R; Dubis AM; Gunnemann F; Rothaus K; Charbel Issa P; Heeren TF; Peto T; Clemons TE; Chew EY; Bird AC; Sallo FB;
    Acta Ophthalmol; 2019 Nov; 97(7):e998-e1005. PubMed ID: 30968592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation Between Macular Integrity Assessment and Optical Coherence Tomography Imaging of Ellipsoid Zone in Macular Telangiectasia Type 2.
    Mukherjee D; Lad EM; Vann RR; Jaffe SJ; Clemons TE; Friedlander M; Chew EY; Jaffe GJ; Farsiu S;
    Invest Ophthalmol Vis Sci; 2017 May; 58(6):BIO291-BIO299. PubMed ID: 28973315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of retinal microvascular changes in macular telangiectasia type 2 using optical coherence tomography angiography.
    Park YG; Park YH
    PLoS One; 2020; 15(4):e0232255. PubMed ID: 32348375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of vascular changes in macular telangiectasia type 2: comparison between SD-OCT and OCT angiography.
    Pauleikhoff D; Gunnemann F; Book M; Rothaus K
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1381-1392. PubMed ID: 31093765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FUNCTIONAL AND STRUCTURAL EFFECTS OF NONDAMAGING RETINAL LASER THERAPY FOR MACULAR TELANGIECTASIA TYPE 2: A Randomized Sham-Controlled Clinical Trial.
    Lavinsky D; Silva MOD; Chaves AE; Schneider WFM; Lavinsky F; Palanker D
    Retina; 2021 Mar; 41(3):487-494. PubMed ID: 33370517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeleton density and ellipsoid zone loss are prognostic for progression in Macular Telangiectasia Type 2.
    Goerdt L; Berger M; Jungblut J; Rodriguez Garcia JL; Pfau K; Herrmann P; Holz FG; Wintergerst MWM
    Sci Rep; 2024 Jul; 14(1):17328. PubMed ID: 39068228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multilayer Retinal Correspondence of the Structural and Vascular Anomalies in Eyes With Early Macular Telangiectasia Type 2.
    Krivosic V; Dobbels Z; Duliere C; Zureik A; Tadayoni R; Gaudric A
    Invest Ophthalmol Vis Sci; 2024 Sep; 65(11):24. PubMed ID: 39283616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OCT of Outer Retinal Hyperreflectivity, Neovascularization, and Pigment in Macular Telangiectasia Type 2.
    Krivosic V; Lavia C; Aubineau A; Tadayoni R; Gaudric A
    Ophthalmol Retina; 2021 Jun; 5(6):562-570. PubMed ID: 32956858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OCT Angiography and Ellipsoid Zone Mapping of Macular Telangiectasia Type 2 From the AVATAR Study.
    Runkle AP; Kaiser PK; Srivastava SK; Schachat AP; Reese JL; Ehlers JP
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3683-3689. PubMed ID: 28727884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CORRELATION OF CLINICAL AND STRUCTURAL PROGRESSION WITH VISUAL ACUITY LOSS IN MACULAR TELANGIECTASIA TYPE 2: MacTel Project Report No. 6-The MacTel Research Group.
    Peto T; Heeren TFC; Clemons TE; Sallo FB; Leung I; Chew EY; Bird AC
    Retina; 2018 Jan; 38 Suppl 1(Suppl 1):S8-S13. PubMed ID: 28505012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staging of macular telangiectasia: power-Doppler optical coherence tomography and macular pigment optical density.
    Chin EK; Kim DY; Hunter AA; Pilli S; Wilson M; Zawadzki RJ; Werner JS; Park SS
    Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4459-70. PubMed ID: 23716628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FLUORESCENCE LIFETIME PATTERNS IN MACULAR TELANGIECTASIA TYPE 2.
    Solberg Y; Dysli C; Wolf S; Zinkernagel MS
    Retina; 2020 Jan; 40(1):99-108. PubMed ID: 30664123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overlap between telangiectasia and photoreceptor loss increases with progression of macular telangiectasia type 2.
    Micevych PS; Lee HE; Fawzi AA
    PLoS One; 2019; 14(10):e0224393. PubMed ID: 31658282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MACULAR TELANGIECTASIA TYPE 2: Acircularity Index and Quantitative Assessment of Foveal Avascular Zone Using Optical Coherence Tomography Angiography.
    Ersoz MG; Hocaoglu M; Sayman Muslubas I; Arf S; Karacorlu M
    Retina; 2020 Jun; 40(6):1132-1139. PubMed ID: 30893277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast sensitivity and visual acuity under low light conditions in macular telangiectasia type 2.
    Müller S; Heeren TFC; Bonelli R; Fruttiger M; Charbel Issa P; Egan CA; Holz FG
    Br J Ophthalmol; 2019 Mar; 103(3):398-403. PubMed ID: 29858186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epiretinal Neovascularization: A Novel OCT Angiography Finding in Macular Telangiectasia Type 2.
    Ayachit AG; Reddy LU; Joshi S; Ayachit GS
    Ophthalmol Retina; 2019 Jun; 3(6):516-522. PubMed ID: 31174674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.